$SGRY
Surgery Partners, Inc. Stock $sgry

$sgry Overview Financials Valuation SEC Filings Company Website

2016 Q4 Form 10-K Financial Statement

#000163883317000007 Filed on March 10, 2017

Income Statement

Concept	2016 Q4	2016 Q3	2016
Revenue	$306.0M	$282.7M	$1.145B
YoY Change	16.21%	17.98%	19.33%
Cost Of Revenue	$214.2M	$201.4M	$821.2M
YoY Change	16.96%	19.29%	22.69%
Gross Profit	$91.75M	$81.29M	$324.2M
YoY Change	14.48%	14.85%	11.59%
Gross Profit Margin	29.98%	28.76%	28.31%
Selling, General & Admin	$39.80M	$36.70M	$136.6M
YoY Change	-1.0%	29.68%	9.81%
% of Gross Profit	43.38%	45.15%	42.13%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$10.60M	$9.713M	$39.55M
YoY Change	17.78%	12.8%	14.49%
% of Gross Profit	11.55%	11.95%	12.2%
Operating Expenses	$50.40M	$239.8M	$949.0M
YoY Change	2.65%	22.79%	16.42%
Operating Profit	$41.35M	$42.85M	$196.5M
YoY Change	33.19%	-3.22%	35.74%
Interest Expense	-$23.90M	-$26.48M	-$100.6M
YoY Change	10.65%	-0.37%	-0.41%
% of Operating Profit	-57.79%	-61.79%	-51.19%
Other Income/Expense, Net	$700.0K	-$4.100M	-$3.400M
YoY Change	-100.59%	-1466.67%	-97.11%
Pretax Income	$42.70M	$12.64M	$92.18M
YoY Change	-135.2%	-28.59%	-221.07%
Income Tax	$4.600M	-$1.694M	$7.095M
% Of Pretax Income	10.77%	-13.4%	7.7%
Net Earnings	$16.86M	-$2.338M	$9.453M
YoY Change	0.73%	-25.11%	561.51%
Net Earnings / Revenue	5.51%	-0.83%	0.83%
Basic Earnings Per Share	$0.35	-$0.05	$0.20
Diluted Earnings Per Share	$0.35	-$0.05	$0.20
COMMON SHARES
Basic Shares Outstanding	48.49M shares	48.02M shares	48.02M shares
Diluted Shares Outstanding		48.02M shares	48.19M shares

Balance Sheet

Concept	2016 Q4	2016 Q3	2016
SHORT-TERM ASSETS
Cash & Short-Term Investments	$69.70M	$55.20M	$69.70M
YoY Change	20.38%	-2.82%	20.38%
Cash & Equivalents	$69.70M	$55.21M	$69.70M
Short-Term Investments
Other Short-Term Assets	$11.34M	$10.39M	$33.40M
YoY Change	34.75%	7.51%	12.08%
Inventory	$28.78M	$26.87M	$28.80M
Prepaid Expenses	$11.16M	$11.52M
Receivables	$220.6M	$206.0M	$220.6M
Other Receivables	$9.500M	$9.500M	$9.500M
Total Short-Term Assets	$362.0M	$328.7M	$362.0M
YoY Change	16.4%	14.14%	16.4%
LONG-TERM ASSETS
Property, Plant & Equipment	$204.3M	$199.6M	$204.3M
YoY Change	10.67%	14.84%	10.67%
Goodwill	$1.555B	$1.531B
YoY Change	10.46%	15.14%
Intangibles	$48.02M	$48.67M
YoY Change	-10.35%	-8.4%
Long-Term Investments	$39.50M	$39.40M	$39.50M
YoY Change	7.05%	7.65%	7.05%
Other Assets	$16.44M	$13.83M	$95.30M
YoY Change	56.39%	84.15%	-13.6%
Total Long-Term Assets	$1.943B	$1.920B	$1.943B
YoY Change	8.34%	19.74%	8.34%
TOTAL ASSETS
Total Short-Term Assets	$362.0M	$328.7M	$362.0M
Total Long-Term Assets	$1.943B	$1.920B	$1.943B
Total Assets	$2.305B	$2.249B	$2.305B
YoY Change	9.53%	18.88%	9.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$49.77M	$44.45M	$49.80M
YoY Change	9.76%	8.93%	9.93%
Accrued Expenses	$71.00M	$69.80M	$71.00M
YoY Change	31.73%	36.59%	31.73%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$27.80M	$29.10M	$27.80M
YoY Change	2.21%	5.05%	2.21%
Total Short-Term Liabilities	$186.7M	$178.7M	$186.7M
YoY Change	3.0%	1.41%	2.98%
LONG-TERM LIABILITIES
Long-Term Debt	$1.467B	$1.411B	$1.467B
YoY Change	14.44%	-1.01%	14.44%
Other Long-Term Liabilities	$76.27M	$87.43M	$146.0M
YoY Change	-10.92%	4.36%	-8.58%
Total Long-Term Liabilities	$76.27M	$87.43M	$1.613B
YoY Change	-10.92%	4.36%	11.89%
TOTAL LIABILITIES
Total Short-Term Liabilities	$186.7M	$178.7M	$186.7M
Total Long-Term Liabilities	$76.27M	$87.43M	$1.613B
Total Liabilities	$263.0M	$266.1M	$2.295B
YoY Change	-1.47%	2.36%	8.86%
SHAREHOLDERS EQUITY
Retained Earnings	-$311.4M	-$328.2M
YoY Change	-2.95%	-2.76%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$9.677M	-$8.331M	$9.700M
YoY Change
Total Liabilities & Shareholders Equity	$2.305B	$2.249B	$2.305B
YoY Change	9.53%	18.88%	9.53%

Cashflow Statement

Concept	2016 Q4	2016 Q3	2016
OPERATING ACTIVITIES
Net Income	$16.86M	-$2.338M	$9.453M
YoY Change	0.73%	-25.11%	561.51%
Depreciation, Depletion And Amortization	$10.60M	$9.713M	$39.55M
YoY Change	17.78%	12.8%	14.49%
Cash From Operating Activities	$32.30M	$18.90M	$125.2M
YoY Change	33.47%	-35.49%	48.25%
INVESTING ACTIVITIES
Capital Expenditures	-$10.70M	-$8.000M	$39.11M
YoY Change	-30.07%	21.21%	16.96%
Acquisitions			$146.4M
YoY Change			30.03%
Other Investing Activities	-$19.60M	-$13.00M	-$145.6M
YoY Change	-75.5%	-35.64%	43.59%
Cash From Investing Activities	-$30.30M	-$21.00M	-$184.7M
YoY Change	-68.21%	-21.64%	37.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net			$473.4M
YoY Change			44.2%
Cash From Financing Activities	12.50M	5.800M	$71.28M
YoY Change	-82.71%	-9.38%	113.57%
NET CHANGE
Cash From Operating Activities	32.30M	18.90M	$125.2M
Cash From Investing Activities	-30.30M	-21.00M	-$184.7M
Cash From Financing Activities	12.50M	5.800M	$71.28M
Net Change In Cash	14.50M	3.700M	$11.77M
YoY Change	1108.33%	-58.43%	-169.26%
FREE CASH FLOW
Cash From Operating Activities	$32.30M	$18.90M	$125.2M
Capital Expenditures	-$10.70M	-$8.000M	$39.11M
Free Cash Flow	$43.00M	$26.90M	$86.13M
YoY Change	8.86%	-25.07%	68.74%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016	dei	Amendment Flag AmendmentFlag	false
CY2016	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2016	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2016	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016	dei	Document Period End Date DocumentPeriodEndDate	2016-12-31
CY2016	dei	Document Type DocumentType	10-K
CY2016	dei	Entity Central Index Key EntityCentralIndexKey	0001638833
CY2017Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	48625166	shares
CY2016	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2016	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2016Q2	dei	Entity Public Float EntityPublicFloat	255700000	USD
CY2016	dei	Entity Registrant Name EntityRegistrantName	Surgery Partners, Inc.
CY2016	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2016	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2015Q4	sgry	Acquisitionescrowreceivablecurrent Acquisitionescrowreceivablecurrent	8000000	USD
CY2016Q4	sgry	Acquisitionescrowreceivablecurrent Acquisitionescrowreceivablecurrent	0	USD
CY2014	sgry	Amortizationof Unfavorable Lease Liability AmortizationofUnfavorableLeaseLiability	72000	USD
CY2015	sgry	Amortizationof Unfavorable Lease Liability AmortizationofUnfavorableLeaseLiability	431000	USD
CY2016	sgry	Amortizationof Unfavorable Lease Liability AmortizationofUnfavorableLeaseLiability	431000	USD
CY2015Q4	sgry	Business Acquisition Contingent Acquisition Compensation Liability Current BusinessAcquisitionContingentAcquisitionCompensationLiabilityCurrent	0	USD
CY2016Q4	sgry	Business Acquisition Contingent Acquisition Compensation Liability Current BusinessAcquisitionContingentAcquisitionCompensationLiabilityCurrent	4589000	USD
CY2015	sgry	Business Acquisition Numberof Physicians Addedto Network BusinessAcquisitionNumberofPhysiciansAddedtoNetwork	17	Physician
CY2015Q4	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	12300000	USD
CY2015Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	2005000	USD
CY2016Q4	sgry	Escrow Liability Noncurrent EscrowLiabilityNoncurrent	0	USD
CY2015Q4	sgry	Estimated Insurance Recoveries Current EstimatedInsuranceRecoveriesCurrent	2363000	USD
CY2016Q4	sgry	Estimated Insurance Recoveries Current EstimatedInsuranceRecoveriesCurrent	2476000	USD
CY2015Q4	sgry	Estimated Insurance Recoveries Noncurrent EstimatedInsuranceRecoveriesNoncurrent	3976000	USD
CY2016Q4	sgry	Estimated Insurance Recoveries Noncurrent EstimatedInsuranceRecoveriesNoncurrent	6835000	USD
CY2016	sgry	Finite Lived Intangible Asset Disposals FiniteLivedIntangibleAssetDisposals	135000	USD
CY2015Q4	sgry	Business Combination Consideration Transferred Payable Current BusinessCombinationConsiderationTransferredPayableCurrent	16768000	USD
CY2016Q4	sgry	Business Combination Consideration Transferred Payable Current BusinessCombinationConsiderationTransferredPayableCurrent	0	USD
CY2014	sgry	Business Combination Contingent Compensation Expense BusinessCombinationContingentCompensationExpense	0	USD
CY2015	sgry	Business Combination Contingent Compensation Expense BusinessCombinationContingentCompensationExpense	0	USD
CY2016	sgry	Business Combination Contingent Compensation Expense BusinessCombinationContingentCompensationExpense	5092000	USD
CY2015Q4	sgry	Business Combination Indemnification Assets Receivable BusinessCombinationIndemnificationAssetsReceivable	1072000	USD
CY2016Q4	sgry	Business Combination Indemnification Assets Receivable BusinessCombinationIndemnificationAssetsReceivable	0	USD
CY2014	sgry	Business Combination Integration Related Costs And Merger Costs BusinessCombinationIntegrationRelatedCostsAndMergerCosts	21690000	USD
CY2015	sgry	Business Combination Integration Related Costs And Merger Costs BusinessCombinationIntegrationRelatedCostsAndMergerCosts	20579000	USD
CY2016	sgry	Business Combination Integration Related Costs And Merger Costs BusinessCombinationIntegrationRelatedCostsAndMergerCosts	11617000	USD
CY2015	sgry	Business Combination Practice Acquisition Costs BusinessCombinationPracticeAcquisitionCosts	2659000	USD
CY2016	sgry	Business Combination Practice Acquisition Costs BusinessCombinationPracticeAcquisitionCosts	2879000	USD
CY2015Q3	sgry	Collaborative Tax Agreement Percentageof Cash Savings Requiredto Pay CollaborativeTaxAgreementPercentageofCashSavingsRequiredtoPay	0.85
CY2014	sgry	Debt Instrument Prepayment Penalty Amount DebtInstrumentPrepaymentPenaltyAmount	0	USD
CY2015	sgry	Debt Instrument Prepayment Penalty Amount DebtInstrumentPrepaymentPenaltyAmount	0	USD
CY2016	sgry	Debt Instrument Prepayment Penalty Amount DebtInstrumentPrepaymentPenaltyAmount	4900000	USD
CY2015Q4	sgry	Debt Instrument Unamortized Discount Premiumand Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumandDebtIssuanceCostsNet	30622000	USD
CY2016Q4	sgry	Debt Instrument Unamortized Discount Premiumand Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumandDebtIssuanceCostsNet	32274000	USD
CY2015Q4	sgry	Deferred Tax Asset Tax Receivable Agreement DeferredTaxAssetTaxReceivableAgreement	2750000	USD
CY2016Q4	sgry	Deferred Tax Asset Tax Receivable Agreement DeferredTaxAssetTaxReceivableAgreement	4542000	USD
CY2015Q4	sgry	Deferred Tax Assets Tax Deferred Expense Compensationand Benefits Compensated Absencesand Incentive Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsCompensatedAbsencesandIncentiveCompensation	2212000	USD
CY2016Q4	sgry	Deferred Tax Assets Tax Deferred Expense Compensationand Benefits Compensated Absencesand Incentive Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsCompensatedAbsencesandIncentiveCompensation	1112000	USD
CY2015Q4	sgry	Deferred Tax Assets Tax Deferred Expense Deferred Financing Costs DeferredTaxAssetsTaxDeferredExpenseDeferredFinancingCosts	3083000	USD
CY2016Q4	sgry	Deferred Tax Assets Tax Deferred Expense Deferred Financing Costs DeferredTaxAssetsTaxDeferredExpenseDeferredFinancingCosts	0	USD
CY2015Q4	sgry	Deferred Tax Liabilities Basis Differencesof Partnershipsand Joint Ventures DeferredTaxLiabilitiesBasisDifferencesofPartnershipsandJointVentures	46494000	USD
CY2016Q4	sgry	Deferred Tax Liabilities Basis Differencesof Partnershipsand Joint Ventures DeferredTaxLiabilitiesBasisDifferencesofPartnershipsandJointVentures	68160000	USD
CY2014	sgry	Earnings Before Interest Taxes Depreciationand Amortization EarningsBeforeInterestTaxesDepreciationandAmortization	77034000	USD
CY2015	sgry	Earnings Before Interest Taxes Depreciationand Amortization EarningsBeforeInterestTaxesDepreciationandAmortization	158053000	USD
CY2016	sgry	Earnings Before Interest Taxes Depreciationand Amortization EarningsBeforeInterestTaxesDepreciationandAmortization	179263000	USD
CY2014	sgry	Effective Income Tax Rate Reconciliation Expirationof Carryforwardsand Stock Option Forfeitures Amount EffectiveIncomeTaxRateReconciliationExpirationofCarryforwardsandStockOptionForfeituresAmount	1286000	USD
CY2015	sgry	Effective Income Tax Rate Reconciliation Expirationof Carryforwardsand Stock Option Forfeitures Amount EffectiveIncomeTaxRateReconciliationExpirationofCarryforwardsandStockOptionForfeituresAmount	0	USD
CY2016	sgry	Effective Income Tax Rate Reconciliation Expirationof Carryforwardsand Stock Option Forfeitures Amount EffectiveIncomeTaxRateReconciliationExpirationofCarryforwardsandStockOptionForfeituresAmount	0	USD
CY2014	sgry	Effective Income Tax Rate Reconciliation Nondeductible Mergerand Public Offering Costs Amount EffectiveIncomeTaxRateReconciliationNondeductibleMergerandPublicOfferingCostsAmount	4230000	USD
CY2015	sgry	Effective Income Tax Rate Reconciliation Nondeductible Mergerand Public Offering Costs Amount EffectiveIncomeTaxRateReconciliationNondeductibleMergerandPublicOfferingCostsAmount	3442000	USD
CY2016	sgry	Effective Income Tax Rate Reconciliation Nondeductible Mergerand Public Offering Costs Amount EffectiveIncomeTaxRateReconciliationNondeductibleMergerandPublicOfferingCostsAmount	0	USD
CY2014	sgry	Effective Income Tax Rate Reconciliation Tax Receivable Agreement Amount EffectiveIncomeTaxRateReconciliationTaxReceivableAgreementAmount	0	USD
CY2015	sgry	Effective Income Tax Rate Reconciliation Tax Receivable Agreement Amount EffectiveIncomeTaxRateReconciliationTaxReceivableAgreementAmount	39428000	USD
CY2016	sgry	Effective Income Tax Rate Reconciliation Tax Receivable Agreement Amount EffectiveIncomeTaxRateReconciliationTaxReceivableAgreementAmount	-327000	USD
CY2015Q4	sgry	Escrow Deposit Current EscrowDepositCurrent	13984000	USD
CY2016Q4	sgry	Escrow Deposit Current EscrowDepositCurrent	10871000	USD
CY2015Q4	sgry	Escrow Deposit Noncurrent EscrowDepositNoncurrent	8408000	USD
CY2016Q4	sgry	Escrow Deposit Noncurrent EscrowDepositNoncurrent	0	USD
CY2015Q4	sgry	Escrow Liability Current EscrowLiabilityCurrent	13984000	USD
CY2016Q4	sgry	Escrow Liability Current EscrowLiabilityCurrent	10871000	USD
CY2015Q4	sgry	Escrow Liability Noncurrent EscrowLiabilityNoncurrent	8408000	USD
CY2016Q4	sgry	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentalsin Four Years OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsinFourYears	468000	USD
CY2016Q4	sgry	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentalsin Three Years OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsinThreeYears	658000	USD
CY2016Q4	sgry	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentalsin Two Years OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsinTwoYears	1137000	USD
CY2015	sgry	Operating Leasesof Lessee Numberof Leases Terminated OperatingLeasesofLesseeNumberofLeasesTerminated	4	Lease
CY2015Q4	sgry	Optical Products Receivable OpticalProductsReceivable	8434000	USD
CY2015	sgry	Tax Receivable Agreement Expense TaxReceivableAgreementExpense	119911000	USD
CY2016	sgry	Tax Receivable Agreement Expense TaxReceivableAgreementExpense	3733000	USD
CY2015Q4	sgry	Tax Receivable Agreement Liability Current TaxReceivableAgreementLiabilityCurrent	0	USD
CY2016Q4	sgry	Tax Receivable Agreement Liability Current TaxReceivableAgreementLiabilityCurrent	1000000	USD
CY2013Q2	sgry	Gain Contingency Unrecorded Amount Overstated Accounts Receivable GainContingencyUnrecordedAmountOverstatedAccountsReceivable	10800000	USD
CY2014	sgry	Incentive Payments Recognizedfor Certain Hospitalsand Physician Practices That Demonstrate Meaningful Useof Certified Electronic Health Record Technology IncentivePaymentsRecognizedforCertainHospitalsandPhysicianPracticesThatDemonstrateMeaningfulUseofCertifiedElectronicHealthRecordTechnology	3356000	USD
CY2015	sgry	Incentive Payments Recognizedfor Certain Hospitalsand Physician Practices That Demonstrate Meaningful Useof Certified Electronic Health Record Technology IncentivePaymentsRecognizedforCertainHospitalsandPhysicianPracticesThatDemonstrateMeaningfulUseofCertifiedElectronicHealthRecordTechnology	1761000	USD
CY2016	sgry	Incentive Payments Recognizedfor Certain Hospitalsand Physician Practices That Demonstrate Meaningful Useof Certified Electronic Health Record Technology IncentivePaymentsRecognizedforCertainHospitalsandPhysicianPracticesThatDemonstrateMeaningfulUseofCertifiedElectronicHealthRecordTechnology	408000	USD
CY2015	sgry	Increaseof Revenueas Resultof Changesin Estimatesto Thirdparty Settlements Relatedto Prior Years IncreaseofRevenueasResultofChangesinEstimatestoThirdpartySettlementsRelatedtoPriorYears	2300000	USD
CY2016	sgry	Increaseof Revenueas Resultof Changesin Estimatesto Thirdparty Settlements Relatedto Prior Years IncreaseofRevenueasResultofChangesinEstimatestoThirdpartySettlementsRelatedtoPriorYears	6800000	USD
CY2015	sgry	Intangible Assets Professional Recruitment Expense IntangibleAssetsProfessionalRecruitmentExpense	813000	USD
CY2016	sgry	Intangible Assets Professional Recruitment Expense IntangibleAssetsProfessionalRecruitmentExpense	609000	USD
CY2014	sgry	Intereston Contingent Consideration Obligation InterestonContingentConsiderationObligation	964000	USD
CY2015	sgry	Intereston Contingent Consideration Obligation InterestonContingentConsiderationObligation	1041000	USD
CY2016	sgry	Intereston Contingent Consideration Obligation InterestonContingentConsiderationObligation	1124000	USD
CY2015Q4	sgry	Lease Obligation Noncurrent LeaseObligationNoncurrent	53927000	USD
CY2016Q4	sgry	Lease Obligation Noncurrent LeaseObligationNoncurrent	52653000	USD
CY2016Q4	sgry	Long Term Tax Receivable Agreement Liability LongTermTaxReceivableAgreementLiability	123300000	USD
CY2015Q4	sgry	Medical Malpractice Liability Noncurrent MedicalMalpracticeLiabilityNoncurrent	6339000	USD
CY2016Q4	sgry	Medical Malpractice Liability Noncurrent MedicalMalpracticeLiabilityNoncurrent	10453000	USD
CY2014	sgry	Non Controlling Interest Acquisitionsand Disposalsof Interestsheldby Non Controlling Interest Holders Net NonControllingInterestAcquisitionsandDisposalsofInterestsheldbyNonControllingInterestHoldersNet	202657000	USD
CY2015	sgry	Non Controlling Interest Acquisitionsand Disposalsof Interestsheldby Non Controlling Interest Holders Net NonControllingInterestAcquisitionsandDisposalsofInterestsheldbyNonControllingInterestHoldersNet	3486000	USD
CY2016	sgry	Non Controlling Interest Acquisitionsand Disposalsof Interestsheldby Non Controlling Interest Holders Net NonControllingInterestAcquisitionsandDisposalsofInterestsheldbyNonControllingInterestHoldersNet	6284000	USD
CY2016Q4	sgry	Number Of Surgical Facilities Owned NumberOfSurgicalFacilitiesOwned	104	surgical_facility
CY2016Q4	sgry	Numberof Surgical Facilities Owned Consolidated NumberofSurgicalFacilitiesOwnedConsolidated	94	surgical_facility
CY2016Q4	sgry	Numberof Surgical Facilities Owned Majority Interest NumberofSurgicalFacilitiesOwnedMajorityInterest	74	surgical_facility
CY2016Q4	sgry	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Current OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsCurrent	1101000	USD
CY2016Q4	sgry	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Thereafter OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsThereafter	1919000	USD
CY2016Q4	sgry	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Totals OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsTotals	5595000	USD
CY2016Q4	sgry	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentalsin Five Years OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsinFiveYears	312000	USD
CY2016Q4	sgry	Optical Products Receivable OpticalProductsReceivable	7042000	USD
CY2014	sgry	Paymentsof Distributionto Parent PaymentsofDistributiontoParent	93000000	USD
CY2015	sgry	Paymentsof Distributionto Parent PaymentsofDistributiontoParent	0	USD
CY2016	sgry	Paymentsof Distributionto Parent PaymentsofDistributiontoParent	0	USD
CY2015	sgry	Redeemable Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	19936000	USD
CY2016	sgry	Redeemable Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	17160000	USD
CY2015	sgry	Redeemable Noncontrolling Interest Increase Decrease From Redemptions Or Purchase Of Interests RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests	-6830000	USD
CY2016	sgry	Redeemable Noncontrolling Interest Increase Decrease From Redemptions Or Purchase Of Interests RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests	-3781000	USD
CY2014	sgry	Related Party Transaction Annual Management Fee Paidper Agreement RelatedPartyTransactionAnnualManagementFeePaidperAgreement	2161000	USD
CY2015	sgry	Related Party Transaction Annual Management Fee Paidper Agreement RelatedPartyTransactionAnnualManagementFeePaidperAgreement	2250000	USD
CY2016	sgry	Related Party Transaction Annual Management Fee Paidper Agreement RelatedPartyTransactionAnnualManagementFeePaidperAgreement	0	USD
CY2015	sgry	Sharebased Compensation Arrangementby Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm	P3Y
CY2016	sgry	Sharebased Compensation Arrangementby Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm	P1Y7M6D
CY2014	sgry	Stockholders Equity Distributionsto Parent StockholdersEquityDistributionstoParent	93000000	USD
CY2014	sgry	Tax Receivable Agreement Expense TaxReceivableAgreementExpense	0	USD
CY2016Q4	sgry	Tax Receivable Agreement Liability Current TaxReceivableAgreementLiabilityCurrent	999000	USD
CY2015Q4	sgry	Tax Receivable Agreement Liability Noncurrent TaxReceivableAgreementLiabilityNoncurrent	119655000	USD
CY2016Q4	sgry	Tax Receivable Agreement Liability Noncurrent TaxReceivableAgreementLiabilityNoncurrent	122351000	USD
CY2014	sgry	Terminationof Management Agreementand Ipo Costs TerminationofManagementAgreementandIPOCosts	0	USD
CY2015	sgry	Terminationof Management Agreementand Ipo Costs TerminationofManagementAgreementandIPOCosts	5834000	USD
CY2016	sgry	Terminationof Management Agreementand Ipo Costs TerminationofManagementAgreementandIPOCosts	0	USD
CY2015Q4	sgry	Third Party Settlements Payable Current ThirdPartySettlementsPayableCurrent	5200000	USD
CY2015Q4	sgry	Third Party Settlements Payable Current ThirdPartySettlementsPayableCurrent	5222000	USD
CY2016Q4	sgry	Third Party Settlements Payable Current ThirdPartySettlementsPayableCurrent	179000	USD
CY2016Q4	sgry	Third Party Settlements Receivable Current ThirdPartySettlementsReceivableCurrent	454000	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	45341000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	49766000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	177757000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	220594000	USD
CY2015Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	5476000	USD
CY2016Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	6625000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Excluding Capital Leased Assets AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingCapitalLeasedAssets	70238000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Excluding Capital Leased Assets AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingCapitalLeasedAssets	86387000	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	316294000	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	320543000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	640000	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	942000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7502000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2021000	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5028000	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5329000	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	18322000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	29872000	USD
CY2014	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	9208000	USD
CY2015	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	10585000	USD
CY2016	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	12662000	USD
CY2014	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3746000	USD
CY2015	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	6263000	USD
CY2016	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	7199000	USD
CY2014	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5200000	USD
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9091000	USD
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9600000	USD
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9555000	USD
CY2015Q4	us-gaap	Assets Assets	2104443000	USD
CY2016Q4	us-gaap	Assets Assets	2304958000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	310957000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	361955000	USD
CY2014	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	USD
CY2015	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1560000	USD
CY2016	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2185000	USD
CY2015Q4	us-gaap	Cost Of Revenue CostOfRevenue	183174000	USD
CY2015	us-gaap	Cost Of Revenue CostOfRevenue	669326000	USD
CY2016Q1	us-gaap	Cost Of Revenue CostOfRevenue	196703000	USD
CY2016Q2	us-gaap	Cost Of Revenue CostOfRevenue	208852000	USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48156990	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48488616	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48156990	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48488616	shares
CY2015Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	482000	USD
CY2013Q2	us-gaap	Business Combination Assets Arising From Contingencies Amount Recognized BusinessCombinationAssetsArisingFromContingenciesAmountRecognized	14000000	USD
CY2015Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	14049000	USD
CY2016Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	USD
CY2014	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	21690000	USD
CY2015	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	17920000	USD
CY2016	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	8738000	USD
CY2015Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	11316000	USD
CY2016Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	13996000	USD
CY2014	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	3252000	USD
CY2015	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	5443000	USD
CY2016	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	7866000	USD
CY2016Q4	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	15400000	USD
CY2015Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	10500000	USD
CY2016Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	11600000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13026000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	74920000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	57933000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69699000	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	61894000	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-16987000	USD
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	11766000	USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	485000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-65897000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1429000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	9453000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	38845000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	71416000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	75630000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-27052000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	72845000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	85083000	USD
CY2014	us-gaap	Cost Of Revenue CostOfRevenue	254178000	USD
CY2015Q1	us-gaap	Cost Of Revenue CostOfRevenue	155773000	USD
CY2015Q2	us-gaap	Cost Of Revenue CostOfRevenue	161558000	USD
CY2015Q3	us-gaap	Cost Of Revenue CostOfRevenue	168821000	USD
CY2014	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-444000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	2052000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	2785000	USD
CY2016Q3	us-gaap	Cost Of Revenue CostOfRevenue	201394000	USD
CY2016Q4	us-gaap	Cost Of Revenue CostOfRevenue	214247000	USD
CY2016	us-gaap	Cost Of Revenue CostOfRevenue	821196000	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2015Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	165049000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	186552000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	94105000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	83793000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	94105000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	83793000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	158100000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	146663000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	158796000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3286000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	4879000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	0	USD
CY2016Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	530000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	179194000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	1846000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	8343000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies	869000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies	4194000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	2288000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	1371000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6900000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6949000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7400000	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-31000	USD
CY2014	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1669000	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	909000	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	244000	USD
CY2015Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	1608000	USD
CY2016Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	1725000	USD
CY2015Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	1606000	USD
CY2016Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	1725000	USD
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	13235000	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-132311000	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	7326000	USD
CY2016Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	1488000	USD
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	14089000	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-149891000	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	6882000	USD
CY2015Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	63995000	USD
CY2016Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	95401000	USD
CY2014	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	854000	USD
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-17580000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7358000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Financing Costs DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts	0	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Financing Costs DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts	8797000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	16083000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	15241000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	612000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	3203000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	806000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	0	USD
CY2016Q4	us-gaap	Deferred Taxes Business Combination Valuation Allowance Allocated To Contributed Capital DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital	2400000	USD
CY2014	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	754000	USD
CY2015	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2200000	USD
CY2016	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	5100000	USD
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	15061000	USD
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	34545000	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	39551000	USD
CY2014	us-gaap	Dividends Sharebased Compensation Stock DividendsSharebasedCompensationStock	942000	USD
CY2015	us-gaap	Dividends Sharebased Compensation Stock DividendsSharebasedCompensationStock	7502000	USD
CY2016	us-gaap	Dividends Sharebased Compensation Stock DividendsSharebasedCompensationStock	2021000	USD
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.04
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2015Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.35
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.35
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.04
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2015Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.20
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	26307000	USD
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	29273000	USD
CY2016Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	4700000	USD
CY2015Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	6300000	USD
CY2016Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	9300000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2960000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	4023000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	14660000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	9042000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	6393000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	6923000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	44001000	USD
CY2015	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	8584000	USD
CY2016	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	4754000	USD
CY2015	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	-4600000	USD
CY2014	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-1804000	USD
CY2015	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	2097000	USD
CY2016	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-2355000	USD
CY2014	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
CY2015	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
CY2016	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	14101000	USD
CY2014	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-23414000	USD
CY2015	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-16102000	USD
CY2016	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-11876000	USD
CY2014	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	31452000	USD
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	55992000	USD
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	60246000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	1298753000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	1407927000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	1555204000	USD
CY2015	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	113812000	USD
CY2016	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	147895000	USD
CY2016Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2014	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2015	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2016	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2015	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	3761000	USD
CY2016	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-66000	USD
CY2015	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	8399000	USD
CY2016	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	552000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-11294000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-76137000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	92178000	USD
CY2014	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1264000	USD
CY2015	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	3777000	USD
CY2016	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	4764000	USD
CY2014	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	713000	USD
CY2015	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	543000	USD
CY2016	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	846000	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15758000	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-148982000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7095000	USD
CY2014	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	29336000	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-137721000	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	354000	USD
CY2014	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-2143000	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	USD
CY2014	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3840000	USD
CY2015	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-26648000	USD
CY2016	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	32263000	USD
CY2014	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	13207000	USD
CY2015	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	24996000	USD
CY2016	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	26470000	USD
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	0	USD
CY2015	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	0	USD
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-200000	USD
CY2014	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	381000	USD
CY2015	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	181000	USD
CY2016	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	188000	USD
CY2014	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-4419000	USD
CY2015	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-1574000	USD
CY2016	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	1635000	USD
CY2014	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1402000	USD
CY2015	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1059000	USD
CY2016	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-86000	USD
CY2014	us-gaap	Income Tax Reconciliation Tax Contingencies Other IncomeTaxReconciliationTaxContingenciesOther	589000	USD
CY2015	us-gaap	Income Tax Reconciliation Tax Contingencies Other IncomeTaxReconciliationTaxContingenciesOther	-10000	USD
CY2016	us-gaap	Income Tax Reconciliation Tax Contingencies Other IncomeTaxReconciliationTaxContingenciesOther	-262000	USD
CY2014	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	676000	USD
CY2015	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1093000	USD
CY2016	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	661000	USD
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	20161000	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	48783000	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	60622000	USD
CY2014	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-418000	USD
CY2015	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-4439000	USD
CY2016	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-17203000	USD
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	54888000	USD
CY2015Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	53568000	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	48023000	USD
CY2014	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-62101000	USD
CY2015	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-100980000	USD
CY2016	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-100571000	USD
CY2014	us-gaap	Interest Paid Net InterestPaidNet	50377000	USD
CY2015	us-gaap	Interest Paid Net InterestPaidNet	96799000	USD
CY2016	us-gaap	Interest Paid Net InterestPaidNet	79262000	USD
CY2015Q4	us-gaap	Interest Payable Current InterestPayableCurrent	5410000	USD
CY2016Q4	us-gaap	Interest Payable Current InterestPayableCurrent	19206000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	25591000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	28777000	USD
CY2015Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	34103000	USD
CY2016Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	34980000	USD
CY2014	us-gaap	Labor And Related Expense LaborAndRelatedExpense	101976000	USD
CY2015	us-gaap	Labor And Related Expense LaborAndRelatedExpense	261685000	USD
CY2016	us-gaap	Labor And Related Expense LaborAndRelatedExpense	357175000	USD
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	18800000	USD
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	40100000	USD
CY2016	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	47300000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2104443000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	186725000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	125239000	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-65897000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-6762000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-5426000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-3122000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2304958000	USD
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	16739000	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	1429000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-7190000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	181289000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	2120000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-2338000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	16862000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-134842000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-184749000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	21949000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	84481000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	9453000	USD
CY2014	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	38845000	USD
CY2015Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	17250000	USD
CY2015Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	17905000	USD
CY2015Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	16906000	USD
CY2015Q4	us-gaap	Long Term Accounts Notes And Loans Receivable Net Noncurrent LongTermAccountsNotesAndLoansReceivableNetNoncurrent	212000	USD
CY2016Q4	us-gaap	Long Term Accounts Notes And Loans Receivable Net Noncurrent LongTermAccountsNotesAndLoansReceivableNetNoncurrent	716000	USD
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	1474517000	USD
CY2015Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	1228112000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	1414421000	USD
CY2015Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	27247000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	27822000	USD
CY2015Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	1255359000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	1442243000	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	3950000	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	27823000	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	402852000	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	909993000	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	103871000	USD
CY2016Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	26028000	USD
CY2015Q4	us-gaap	Minority Interest MinorityInterest	301955000	USD
CY2016Q4	us-gaap	Minority Interest MinorityInterest	314997000	USD
CY2014	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	32414000	USD
CY2015	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	49784000	USD
CY2016	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	48618000	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	310961000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	33374000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	71276000	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-271016000	USD
CY2015Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	19355000	USD
CY2016Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	20173000	USD
CY2016Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	16672000	USD
CY2015	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	71416000	USD
CY2016Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	17547000	USD
CY2016Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	21238000	USD
CY2016	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	75630000	USD
CY2015	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	17616000	USD
CY2016	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	18023000	USD
CY2014	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-31131000	USD
CY2015	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	55229000	USD
CY2016	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	67060000	USD
CY2014	us-gaap	Notes Issued1 NotesIssued1	0	USD
CY2015	us-gaap	Notes Issued1 NotesIssued1	7430000	USD
CY2016	us-gaap	Notes Issued1 NotesIssued1	325000	USD
CY2016	us-gaap	Number Of Businesses Acquired NumberOfBusinessesAcquired	1	Entity
CY2016	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2016	us-gaap	Number Of Reporting Units NumberOfReportingUnits	5	reporting_unit
CY2016Q4	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	29	state
CY2015Q4	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	1996000	USD
CY2016Q4	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	1671000	USD
CY2014	us-gaap	Operating Expenses OperatingExpenses	352482000	USD
CY2015	us-gaap	Operating Expenses OperatingExpenses	815137000	USD
CY2016	us-gaap	Operating Expenses OperatingExpenses	948956000	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	50807000	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	144754000	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	196482000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	335316000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	46517000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	28728000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	34415000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	39181000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	42917000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	143558000	USD
CY2014	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	19389000	USD
CY2015	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	44848000	USD
CY2016	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	52147000	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	22133000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	22552000	USD
CY2015Q4	us-gaap	Other Assets Current OtherAssetsCurrent	8414000	USD
CY2016Q4	us-gaap	Other Assets Current OtherAssetsCurrent	11338000	USD
CY2015Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	235000	USD
CY2016Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	1475000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10509000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	16435000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2014	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	20561000	USD
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	14296000	USD
CY2014	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	-278000	USD
CY2015	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	12175000	USD
CY2016	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	20096000	USD
CY2014	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	35182000	USD
CY2015	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	69720000	USD
CY2015	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	54127000	USD
CY2016	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	61450000	USD
CY2015Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	68410000	USD
CY2016Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	68993000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	85613000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	76266000	USD
CY2014	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	-6000	USD
CY2015	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	-525000	USD
CY2016	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	55000	USD
CY2015Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	7694000	USD
CY2016Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	9764000	USD
CY2014	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	0	USD
CY2015	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	119911000	USD
CY2016	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	3733000	USD
CY2015Q4	us-gaap	Payables To Customers PayablesToCustomers	11424000	USD
CY2016Q4	us-gaap	Payables To Customers PayablesToCustomers	12221000	USD
CY2014	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3143000	USD
CY2015	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2016	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2014	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	17840000	USD
CY2015	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	7305000	USD
CY2016	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	USD
CY2014	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	7496000	USD
CY2015	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2016	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	65778000	USD
CY2014	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	263280000	USD
CY2015	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	112596000	USD
CY2016	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	146405000	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7736000	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	33439000	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	39109000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q4	us-gaap	Profit Loss ProfitLoss	36094000	USD
CY2015	us-gaap	Profit Loss ProfitLoss	72845000	USD
CY2016Q1	us-gaap	Profit Loss ProfitLoss	10357000	USD
CY2016Q2	us-gaap	Profit Loss ProfitLoss	22293000	USD
CY2015Q3	us-gaap	Profit Loss ProfitLoss	13784000	USD
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	34620000	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	32014000	USD
CY2015Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7409000	USD
CY2016Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	11158000	USD
CY2014	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
CY2015	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	11193000	USD
CY2016	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	765000	USD
CY2014	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	USD
CY2015	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	250979000	USD
CY2016	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	USD
CY2014	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1477288000	USD
CY2015	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	196366000	USD
CY2016	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	650707000	USD
CY2014	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-70000	USD
CY2015	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	3558000	USD
CY2016	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-924000	USD
CY2014	us-gaap	Professional Fees ProfessionalFees	18028000	USD
CY2015	us-gaap	Professional Fees ProfessionalFees	66583000	USD
CY2016	us-gaap	Professional Fees ProfessionalFees	81185000	USD
CY2014	us-gaap	Profit Loss ProfitLoss	-27052000	USD
CY2015Q1	us-gaap	Profit Loss ProfitLoss	10488000	USD
CY2015Q2	us-gaap	Profit Loss ProfitLoss	12479000	USD
CY2016Q3	us-gaap	Profit Loss ProfitLoss	14334000	USD
CY2016Q4	us-gaap	Profit Loss ProfitLoss	38100000	USD
CY2016	us-gaap	Profit Loss ProfitLoss	85083000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross Excluding Capital Leased Assets PropertyPlantAndEquipmentGrossExcludingCapitalLeasedAssets	254788000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross Excluding Capital Leased Assets PropertyPlantAndEquipmentGrossExcludingCapitalLeasedAssets	290640000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net Excluding Capital Leased Assets PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets	184550000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net Excluding Capital Leased Assets PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets	204253000	USD
CY2014	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	9509000	USD
CY2015	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	23578000	USD
CY2016	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	24212000	USD
CY2014Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	192589000	USD
CY2015Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	183439000	USD
CY2016Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	180521000	USD
CY2014	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1009874000	USD
CY2015	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	328329000	USD
CY2016	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	473437000	USD
CY2015Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	316000	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	7779	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2016Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	315000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-320804000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-311351000	USD
CY2014	us-gaap	Revenues Revenues	403289000	USD
CY2015Q1	us-gaap	Revenues Revenues	224143000	USD
CY2015Q2	us-gaap	Revenues Revenues	232827000	USD
CY2015Q3	us-gaap	Revenues Revenues	239599000	USD
CY2015Q4	us-gaap	Revenues Revenues	263322000	USD
CY2015	us-gaap	Revenues Revenues	959891000	USD
CY2016Q1	us-gaap	Revenues Revenues	267074000	USD
CY2016Q2	us-gaap	Revenues Revenues	289681000	USD
CY2016Q3	us-gaap	Revenues Revenues	282682000	USD
CY2016Q4	us-gaap	Revenues Revenues	306001000	USD
CY2016	us-gaap	Revenues Revenues	1145438000	USD
CY2015Q4	us-gaap	Security Deposit SecurityDeposit	2475000	USD
CY2016Q4	us-gaap	Security Deposit SecurityDeposit	4196000	USD
CY2015Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	9500000	USD
CY2016Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	13800000	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	942000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	7502000	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	2021000	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2829	shares
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	8448	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8488	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	16267	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	20.03
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	19.05
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	20.03
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	17.99
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y9M18D
CY2015	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2016	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2015	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	339000	USD
CY2015	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	250979000	USD
CY2016	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2014	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	3143000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	-4028000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	9677000	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-14375000	USD
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32295364	shares
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29536000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	297927000	USD
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36066233	shares
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48190738	shares
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	324674000	USD
CY2014	us-gaap	Supplies Expense SuppliesExpense	94224000	USD
CY2015	us-gaap	Supplies Expense SuppliesExpense	242083000	USD
CY2016	us-gaap	Supplies Expense SuppliesExpense	269239000	USD
CY2015Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1977000	USD
CY2016Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	2622000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2755000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1403000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1061000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	996000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	398000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	492000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	4000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	322000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	163000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	136000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	60000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	309000	USD
CY2016	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-500000	USD
CY2014	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2015	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1398154	shares
CY2016	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	171794	shares
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32295364	shares
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37464387	shares
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48018944	shares
CY2016	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;text-align:left;padding-left:24px;text-indent:-24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Organization</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">Surgery Partners, Inc.</font><font style="font-family:inherit;font-size:9pt;">,</font><font style="font-family:inherit;font-size:10pt;"> a </font><font style="font-family:inherit;font-size:9pt;">Delaware corporation (together with its subsidiaries, the “Company”), was formed April 2, 2015, as a holding company for the purpose of facilitating an initial public offering (the “IPO”) of shares of common stock. Prior to September 30, 2015, the Company conducted business through Surgery Center Holdings, Inc. and its subsidiaries. Surgery Center Holdings, LLC was and is the sole direct owner of the equity interests of Surgery Center Holdings, Inc. and had no other material assets. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On September 30, 2015, Surgery Partners, Inc. became the direct parent and sole member of Surgery Center Holdings, LLC (the "Reorganization"). In the Reorganization, all of the equity interests held by the pre-IPO Owners of Surgery Center Holdings, LLC were contributed to Surgery Partners, Inc. in exchange for </font><font style="font-family:inherit;font-size:9pt;">33,871,990</font><font style="font-family:inherit;font-size:9pt;"> shares of common stock of Surgery Partners, Inc. and certain rights to additional payments under a tax receivable agreement. After giving effect to the Reorganization, Surgery Partners, Inc. is a holding company, and its sole material asset is an equity interest in Surgery Center Holdings, LLC. The Company's consolidated financial statements for periods prior to the Reorganization represent the historical operating results and financial position of Surgery Center Holdings, Inc. and certain of its subsidiaries.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On </font><font style="font-family:inherit;font-size:9pt;">October 1, 2015</font><font style="font-family:inherit;font-size:9pt;">, the Company completed its IPO of </font><font style="font-family:inherit;font-size:9pt;">14,285,000</font><font style="font-family:inherit;font-size:9pt;"> shares of common stock at an offering price of </font><font style="font-family:inherit;font-size:9pt;">$19.00</font><font style="font-family:inherit;font-size:9pt;"> per share. On </font><font style="font-family:inherit;font-size:9pt;">October 6, 2015</font><font style="font-family:inherit;font-size:9pt;">, the Company received net proceeds from the sale of common stock in this offering of </font><font style="font-family:inherit;font-size:9pt;">$255.8 million</font><font style="font-family:inherit;font-size:9pt;">, after deducting underwriting discounts and other fees of </font><font style="font-family:inherit;font-size:9pt;">$15.6 million</font><font style="font-family:inherit;font-size:9pt;">. These net proceeds were used to repay a portion of the borrowings outstanding under the 2014 Second Lien and to pay fees associated with this offering. The Company also incurred an additional </font><font style="font-family:inherit;font-size:9pt;">$4.8 million</font><font style="font-family:inherit;font-size:9pt;"> in costs directly related to the IPO.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On </font><font style="font-family:inherit;font-size:9pt;">November 3, 2014</font><font style="font-family:inherit;font-size:9pt;">, the Company completed the acquisition of Symbion Holdings Corp. ("Symbion") ("the Merger"), which added </font><font style="font-family:inherit;font-size:9pt;">55</font><font style="font-family:inherit;font-size:9pt;"> surgical facilities, including </font><font style="font-family:inherit;font-size:9pt;">49</font><font style="font-family:inherit;font-size:9pt;"> ambulatory surgery centers ("ASCs") and </font><font style="font-family:inherit;font-size:9pt;">six</font><font style="font-family:inherit;font-size:9pt;"> surgical hospitals, to its network of existing facilities. The Company acquired Symbion for a purchase price of </font><font style="font-family:inherit;font-size:9pt;">$792.0 million</font><font style="font-family:inherit;font-size:9pt;"> pursuant to the terms of an Agreement and Plan of Merger dated as of </font><font style="font-family:inherit;font-size:9pt;">June 13, 2014</font><font style="font-family:inherit;font-size:9pt;">. The Symbion acquisition was financed through the issuance of approximately </font><font style="font-family:inherit;font-size:9pt;">$1.4 billion</font><font style="font-family:inherit;font-size:9pt;"> under the Company's Term Loans and Revolving Facility. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">As of </font><font style="font-family:inherit;font-size:9pt;">December 31, 2016</font><font style="font-family:inherit;font-size:9pt;">, the Company owned and operated a national network of surgical facilities and ancillary services in </font><font style="font-family:inherit;font-size:9pt;">29</font><font style="font-family:inherit;font-size:9pt;"> states.  The surgical facilities, which include ASCs and surgical hospitals, primarily provide non-emergency surgical procedures across many specialties, including, among others, gastroenterology</font><font style="font-family:inherit;font-size:10pt;"> ("</font><font style="font-family:inherit;font-size:9pt;">GI"), general surgery, ophthalmology, orthopedics and pain management. The Company's surgical hospitals provide services such as diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy and wound care. Ancillary services are comprised of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services, optical services and specialty pharmacy services. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> As of </font><font style="font-family:inherit;font-size:9pt;">December 31, 2016</font><font style="font-family:inherit;font-size:9pt;">, the Company owned or operated a portfolio of </font><font style="font-family:inherit;font-size:9pt;">104</font><font style="font-family:inherit;font-size:9pt;"> surgical facilities, comprised of </font><font style="font-family:inherit;font-size:9pt;">99</font><font style="font-family:inherit;font-size:9pt;"> ASCs and </font><font style="font-family:inherit;font-size:9pt;">five</font><font style="font-family:inherit;font-size:9pt;"> surgical hospitals. The Company owns these facilities in partnership with physicians and, in some cases, healthcare systems in the markets and communities it serves. The Company owned a majority interest in </font><font style="font-family:inherit;font-size:9pt;">74</font><font style="font-family:inherit;font-size:9pt;"> of the surgical facilities and consolidated </font><font style="font-family:inherit;font-size:9pt;">94</font><font style="font-family:inherit;font-size:9pt;"> of these facilities for financial reporting purposes. In addition, the Company owned or operated a network of </font><font style="font-family:inherit;font-size:9pt;">56</font><font style="font-family:inherit;font-size:9pt;"> physician practices.</font></div></div>
CY2016	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Reclassifications</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Certain reclassifications have been made to the comparative periods' financial statements to conform to the current year presentation. </font></div></div>
CY2016	us-gaap	Revenue Recognition Sales Of Services RevenueRecognitionSalesOfServices	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Patient service revenues.</font><font style="font-family:inherit;font-size:9pt;">  The fee charged for healthcare procedures performed in surgical facilities varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, medical supplies, nursing staff and medications.  The fee does not normally include professional fees charged by the patient’s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor.  However, in several surgical facilities, the Company charges for anesthesia services. Ancillary service revenues include fees for patient visits to the Company's physician practices, pharmacy services and diagnostic tests ordered by physicians. Patient service revenues are recognized on the date of service, net of estimated contractual adjustments and discounts from third-party payors, including Medicare and Medicaid.  Changes in estimated contractual adjustments and discounts are recorded in the period of change.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company recognizes revenues in the period in which the services are performed. Patient service revenues and receivables from third-party payors are recorded net of estimated contractual adjustments and allowances, which the Company estimates based on the historical trend of its cash collections and contractual write-offs, accounts receivable agings, established fee schedules, contracts with payors and procedure statistics.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Other service revenues.</font><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;"> </font><font style="font-family:inherit;font-size:9pt;"> Optical service revenues consist of product sales from the Company's optical laboratories as well as handling charges billed to the members of the Company's optical products purchasing organization. The Company's optical products purchasing organization negotiates volume buying discounts with optical products manufacturers. The buying discounts and any handling charges billed to the members of the buying group represent the revenue recognized for financial reporting purposes. Revenue is recognized as orders are shipped to members. The Company bases its estimates for sales returns and discounts on historical experience and has not experienced significant fluctuations between estimated and actual return activity and discounts given. The Company's optical laboratories manufacture and distribute corrective lenses and eyeglasses to ophthalmologists and optometrists. Revenue is recognized when product is shipped, net of allowance for discounts. The Company's marketing products and services businesses recognize revenue when product is shipped or services are rendered. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other revenues include management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method, management of surgical facilities in which it does not own an interest, and management services provided to physician practices for which the Company is not required to provide capital or additional assets. The fees derived from these management arrangements are based on a predetermined percentage of the revenues of each facility or practice and are recognized in the period in which services are rendered.</font></div></div>
CY2016	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP"). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All adjustments are of a normal, recurring nature. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001638833-17-000007-index-headers.html	Edgar Link	pending
0001638833-17-000007-index.html	Edgar Link	pending
0001638833-17-000007.txt	Edgar Link	pending
0001638833-17-000007-xbrl.zip	Edgar Link	pending
a201610-kfiling.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
report.css	Edgar Link	pending
sgry-20161231.xml	Edgar Link	completed
sgry-20161231.xsd	Edgar Link	pending
sgry-20161231_cal.xml	Edgar Link	unprocessable
sgry-20161231_def.xml	Edgar Link	unprocessable
sgry-20161231_lab.xml	Edgar Link	unprocessable
sgry-20161231_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending
stockperformancechart2016.jpg	Edgar Link	pending
ye2016exhibit211.htm	Edgar Link	pending
ye2016exhibit231.htm	Edgar Link	pending
ye2016exhibit311.htm	Edgar Link	pending
ye2016exhibit312.htm	Edgar Link	pending
ye2016exhibit321.htm	Edgar Link	pending
ye2016exhibit322.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SGRY
Surgery Partners, Inc. Stock $sgry

2016 Q4 Form 10-K Financial Statement

#000163883317000007 Filed on March 10, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGRY Surgery Partners, Inc. Stock $sgry

2016 Q4 Form 10-K Financial Statement

#000163883317000007 Filed on March 10, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGRY
Surgery Partners, Inc. Stock $sgry